In head and neck squamous cell carcinoma and liver cancer, the low expression of RIPK1 is associated with poor prognosis, while in breast cancer (BC) and glioblastoma, the high expression of RIPK1 leads to poor prognosis. The gene discussed is RIPK1; the disease is head and neck squamous cell carcinoma.